NO20042907L - Deutererte, substituerte dihydrofuranoner og medikamenter som inneholder disse forbindelsene - Google Patents

Deutererte, substituerte dihydrofuranoner og medikamenter som inneholder disse forbindelsene

Info

Publication number
NO20042907L
NO20042907L NO20042907A NO20042907A NO20042907L NO 20042907 L NO20042907 L NO 20042907L NO 20042907 A NO20042907 A NO 20042907A NO 20042907 A NO20042907 A NO 20042907A NO 20042907 L NO20042907 L NO 20042907L
Authority
NO
Norway
Prior art keywords
deuterated
compounds
drugs containing
substituted dihydrofuranones
dihydrofuranones
Prior art date
Application number
NO20042907A
Other languages
English (en)
Norwegian (no)
Inventor
Rudolf-Giesbert Alken
Original Assignee
Turicum Drug Dev Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Turicum Drug Dev Ag filed Critical Turicum Drug Dev Ag
Publication of NO20042907L publication Critical patent/NO20042907L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
NO20042907A 2001-12-12 2004-07-09 Deutererte, substituerte dihydrofuranoner og medikamenter som inneholder disse forbindelsene NO20042907L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10162120A DE10162120A1 (de) 2001-12-12 2001-12-12 Deuterierte substituierte Dihydrofuranone sowie diese Verbindungen enthaltende Arzneimittel
PCT/DE2002/004591 WO2003050101A1 (de) 2001-12-12 2002-12-11 Deuterierte substituierte dihydrofuranone sowie diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
NO20042907L true NO20042907L (no) 2004-07-09

Family

ID=7709639

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042907A NO20042907L (no) 2001-12-12 2004-07-09 Deutererte, substituerte dihydrofuranoner og medikamenter som inneholder disse forbindelsene

Country Status (16)

Country Link
US (1) US7317039B2 (ko)
EP (1) EP1456192A1 (ko)
JP (1) JP2005511742A (ko)
KR (1) KR20040088474A (ko)
CN (1) CN1602304A (ko)
AU (1) AU2002360900A1 (ko)
CA (1) CA2469519A1 (ko)
DE (1) DE10162120A1 (ko)
HU (1) HUP0402304A2 (ko)
IL (1) IL162406A0 (ko)
IS (1) IS7267A (ko)
NO (1) NO20042907L (ko)
NZ (1) NZ533596A (ko)
PL (1) PL369139A1 (ko)
RU (1) RU2004121032A (ko)
WO (1) WO2003050101A1 (ko)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601737B2 (en) * 2005-07-26 2009-10-13 Nycomed Gmbh Isotopically substituted proton pump inhibitors
WO2007140189A2 (en) * 2006-05-26 2007-12-06 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted carboxylic acid compounds
US20080146573A1 (en) * 2006-12-04 2008-06-19 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted oxzolidinones
US20080299216A1 (en) * 2007-06-01 2008-12-04 Protia, Llc Deuterium-enriched aripiprazole
US20090209608A1 (en) * 2007-08-29 2009-08-20 Protia, Llc Deuterium-enriched asenapine
US20090062185A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched anidulafungin
US20090069219A1 (en) * 2007-09-09 2009-03-12 Protia, Llc Deuterium-enriched telavancin
US20090076158A1 (en) * 2007-09-13 2009-03-19 Protia, Llc Deuterium-enriched bicalutamide
US20090075870A1 (en) * 2007-09-17 2009-03-19 Protia, Llc Deuterium-enriched caspofungin
US20090082419A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched tegaserod
AU2009270936B2 (en) 2008-07-15 2014-12-18 Theracos, Inc. Deuterated benzylbenzene derivatives and methods of use
US20100120756A1 (en) * 2008-09-17 2010-05-13 Auspex Pharmaceuticals, Inc. Phenothiazine modulators of h1 receptors
US8227451B2 (en) * 2008-11-12 2012-07-24 Auspex Pharmaceuticals Phenylacetic acid inhibitors of cyclooxygenase
WO2010138889A1 (en) * 2009-05-28 2010-12-02 Concert Pharmaceuticals, Inc. Peptides for the treatment of hcv infections
BR112012008677A2 (pt) 2009-10-12 2018-03-20 Myrexis Inc compostos amino-pirimidina como inibidores de tbkl e/ou ikk epsilon
JP2013527237A (ja) * 2010-06-01 2013-06-27 オースペックス・ファーマシューティカルズ・インコーポレイテッド ベンゾキノロン系ｖｍａｔ２阻害剤
JP6526060B2 (ja) * 2014-02-10 2019-06-05 コンサート ファーマシューティカルズ インコーポレイテッド 置換トリアゾロベンゾジアゼピン
WO2015196186A1 (en) * 2014-06-20 2015-12-23 Intra-Cellular Therapies, Inc. Organic compounds
IL277335B2 (en) 2018-03-21 2024-03-01 Izumi Tech Llc Analogues of alcridar with deuterium

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors

Also Published As

Publication number Publication date
WO2003050101A1 (de) 2003-06-19
HUP0402304A2 (hu) 2005-02-28
US7317039B2 (en) 2008-01-08
EP1456192A1 (de) 2004-09-15
PL369139A1 (en) 2005-04-18
DE10162120A1 (de) 2003-06-18
JP2005511742A (ja) 2005-04-28
CN1602304A (zh) 2005-03-30
AU2002360900A1 (en) 2003-06-23
CA2469519A1 (en) 2003-06-19
RU2004121032A (ru) 2006-01-10
NZ533596A (en) 2005-07-29
IS7267A (is) 2004-05-17
KR20040088474A (ko) 2004-10-16
IL162406A0 (en) 2005-11-20
US20050176814A1 (en) 2005-08-11

Similar Documents

Publication Publication Date Title
NO20042906L (no) Deutererte, substituerte pyrazolybenzylsulfonamider og medikamenter som inneholder disse forbindelsene
NO20042084L (no) 6-hydroksyisoflavoner, derivater og legemidler som omfatter disse
DK1572707T3 (da) Hidtil ukendte aromatiske fluorglycosidderivater, lægemidler indeholdende disse forbindelser og anvendelse heraf
NO20042907L (no) Deutererte, substituerte dihydrofuranoner og medikamenter som inneholder disse forbindelsene
NO20032733L (no) Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse
NL1021822A1 (nl) Tamsulosinetabletten.
DK1401806T3 (da) Benzoylsulfonamider og sulfonylbenzamidiner til anvendelse som antitumormidler
DK1534277T3 (da) Acylerede, heteroaryl-kondenserede cycloalkenylaminer og anvendelse af disse som lægemidler
DK1511734T3 (da) Forbindelser, præparater og fremgangsmåder
IS7798A (is) Efnasambönd, lyfjablöndur og aðferðir
DE60225686D1 (de) Paracetamol enthaltende tablette
ATE434435T1 (de) Pharmazeutische zubereitungen enthaltend modafinil
NO20035798L (no) Tablett som inneholder cetirizin og pseudoefedrin
NO20042337L (no) Deutererte pyrazolopyimidinoner sa vel som legemidler som inneholder disse forbindelser
DK1263719T3 (da) N-deacetylthiocolchin-derivater og farmaceutiske sammensætninger indeholdende disse.
NO20013816L (no) Benzamidderivater og legemidler som inneholder disse
DK1215213T3 (da) Bicylliske aminopyrazinonderivater, fremstilling deraf og farmaceutiske sammensætninger, som indeholder disse
DK1299373T3 (da) Cykliske substituerede aminomethylforbindelser og lægemidler indeholdnede disse forbindelser
FI5009U1 (fi) Tabletti
UA5503S (uk) Пляшка
UA5174S (uk) Пляшка
UA5642S (uk) Пляшка
UA5100S (uk) Пляшка
UA5502S (uk) Пляшка
UA5464S (uk) Пляшка

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application